drugset / Trial / NCT04429867
Hydroxychloroquine Use in Hospitalized Patients With COVID-19: Impact on Progression to Severe or Critical Disease
RandomizedParallel-groupDouble-blindTreatment
Summary
The primary objective is to assess the impact of hydroxychloroquine in hospitalized patients with COVID-19 and risk factors for severe/critical disease.
Timeline
- Start
- 2020-05-07
- Primary completion
- 2020-12-07
- Completion
- 2020-12-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Hydroxychloroquine | Small molecule | 200 mg | Oral |